Breaking News
felene vodka
Home / Top News / Dyne Therapeutics to Host Virtual Research and Development Day on Wednesday, October 13, 2021

Dyne Therapeutics to Host Virtual Research and Development Day on Wednesday, October 13, 2021

Posted by: GlobeNewswire in Top News 26 days ago

– “The Muscle to Move to the Clinic” Event Will Highlight Preclinical Data Supporting Advancement of Dyne’s DM1 and DMD Programs Toward Clinical Trials and Anticipated Timelines, and Feature Leading Experts in Both Disease Areas –

WALTHAM, Mass., Sept. 28, 2021 (GLOBE NEWSWIRE) —  Dyne Therapeutics, Inc. (Nasdaq: DYN), a muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, will host a virtual Research and Development Day on Wednesday, October 13, 2021 from 8:00 – 10:30 a.m. ET. “The Muscle to Move to the Clinic” event will focus on Dyne’s co-lead development programs for rare muscle diseases, myotonic dystrophy type 1 (DM1) and Duchenne muscular dystrophy (DMD).

The program will feature presentations, discussion and Q&A with the following speakers:

  • Valeria Sansone, M.D., Ph.D., Clinical and Scientific Director, Clinical Center NeMO, Milan; Associate Professor of Neurology, University of Milan
  • John Day, M.D., Ph.D., Professor of Neurology and Pediatrics, and Director of the Neuromuscular Division, Stanford Neuroscience Health Center
  • Joshua Brumm, President and Chief Executive Officer: Dyne’s mission, key program updates and milestones
  • Oxana Beskrovnaya, Ph.D., Chief Scientific Officer: FORCE™ platform and review of preclinical data for Dyne’s DM1 and DMD programs, including new in vivo data presented during the World Muscle Society 2021 Virtual Congress and the 2021 Muscle Study Group Annual Scientific Meeting
  • Wildon Farwell, M.D., MPH, Chief Medical Officer: preparations for advancing both programs into the clinic and initial plans for clinical trials

A live webcast of the event will be available in the Events & Presentations page of the Investors & Media section of Dyne’s website and a replay will be accessible for 90 days following the presentation. An accompanying slide presentation will also be available. To register for the live webcast and replay, please visit: https://investors.dyne-tx.com/events/event-details/dyne-rd-day.

About Dyne Therapeutics

Dyne Therapeutics is building a leading muscle disease company dedicated to advancing innovative life-transforming therapeutics for people living with genetically driven diseases. With its proprietary FORCE™ platform, Dyne is developing modern oligonucleotide therapeutics that are designed to overcome limitations in delivery to muscle tissue seen with other approaches. Dyne’s broad portfolio of therapeutic candidates for serious muscle diseases includes programs for myotonic dystrophy type 1 (DM1), Duchenne muscular dystrophy (DMD) and facioscapulohumeral muscular dystrophy (FSHD). For more information, please visit https://www.dyne-tx.com/, and follow us on Twitter, LinkedIn and Facebook.

Contact:

Dyne Therapeutics
Amy Reilly
areilly@dyne-tx.com 
857-341-1203

GlobeNewswire
Latest posts by GlobeNewswire (see all)
Risk Disclaimer - By using this web site you agree to its terms and conditions. All materials, including but not limited to articles, directories, photos, lists, etc., on this website are the sole property of ForexTV or the respective copyright holders and are intended for informational/educational purposes using hypothetical and sometimes anecdotal illustrations. The unauthorized use of any and all materials is prohibited and restricted by copyright law. Any use of materials on this site must be approved in advance by ForexTV. Before deciding to invest in foreign exchange you should carefully consider your investment objectives, level of experience, and risk appetite. The possibility exists that you could sustain a loss of some or all of your initial investment and therefore you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with foreign exchange trading, and seek advice from an independent financial advisor if you have any doubts. Forex (or FX or off-exchange foreign currency futures and options) trading involves substantial risk of loss and is not suitable for every investor. The value of currencies may fluctuate and investors may lose all or more than their original investments. Risks also include, but are not limited to, the potential for changing political and/or economic conditions that may substantially affect the price and/or liquidity of a currency. The impact of seasonal and geopolitical events is already factored into market prices. The leveraged nature of FX trading means that any market movement will have an equally proportional effect on your deposited funds and such may work against you as well as for you. Past results are no indication of future performance. Information contained this web site is intended for informational purposes only and was obtained from sources believed to be reliable. Information is in no way guaranteed. No guarantee of any kind is implied or possible where projections of future conditions are attempted.

© Copyright ForexTV 2021, All Rights Reserved.